Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4081 AL 4095

Alzheimer's Disease-Related Dementias Summit 2016: National research priorities

Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, Marder KS, Moy CS, Phelps CH, Scott PA, Seeley WW, Sieber BA, Silverberg NB, Sutherland ML, Taylor A, Torborg CL, Waddy SP, Gubitz AK, Holtzman DM.

Neurology. 2017 Dec 5;89(23):2381-2391. doi: 10.1212/WNL.0000000000004717. Epub 2017 Nov 8.

A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient

Chao PC, Li JC, Yeh TC, Yeh CB.

Aust N Z J Psychiatry. 2018 Feb;52(2):204-205. doi: 10.1177/0004867417741983. Epub 2017 Nov 9.

Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer's Disease: Systematic Review and Network Metaanalysis

Tricco AC, Ashoor HM, Soobiah C, Rios P, Veroniki AA, Hamid JS, Ivory JD, Khan PA, Yazdi F, Ghassemi M, Blondal E, Ho JM, Ng CH, Hemmelgarn B, Majumdar SR, Perrier L, Straus SE.

J Am Geriatr Soc. 2018 Jan;66(1):170-178. doi: 10.1111/jgs.15069. Epub 2017 Sep 29.

A benzothiazole/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats

Demir Özkay Ü, Can ÖD, Sağlık BN, Turan N.

Pharmacol Rep. 2017 Dec;69(6):1349-1356. doi: 10.1016/j.pharep.2017.06.009. Epub 2017 Jun 30.

Novel Treatment Strategies Using TiO(2)-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease

Sharma A, Menon PK, Patnaik R, Muresanu DF, Lafuente JV, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma HS.

Int Rev Neurobiol. 2017;137:123-165. doi: 10.1016/bs.irn.2017.09.002. Epub 2017 Nov 6.

Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease

Kurochkin IV, Guarnera E, Berezovsky IN.

Trends Pharmacol Sci. 2018 Jan;39(1):49-58. doi: 10.1016/j.tips.2017.10.008. Epub 2017 Nov 10.

Caregiver burden regarding elderly with bipolar disorder: An underrecognized problem

Santos GD, Ladeira RB, Almeida JG, Aprahamian I, Forlenza OV, Lafer B, Nunes PV.

Gen Hosp Psychiatry. 2018 Mar-Apr;51:134-135. doi: 10.1016/j.genhosppsych.2017.10.011. Epub 2017 Nov 7.

A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia

Renn BN, Asghar-Ali AA, Thielke S, Catic A, Martini SR, Mitchell BG, Kunik ME.

Am J Geriatr Psychiatry. 2018 Feb;26(2):134-147. doi: 10.1016/j.jagp.2017.09.027. Epub 2017 Oct 10.

Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models

Gugliandolo A, Bramanti P, Mazzon E.

Int J Mol Sci. 2017 Nov 23;18(12):2504. doi: 10.3390/ijms18122504.

Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease

Seo EJ, Fischer N, Efferth T.

Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.

Intranasal insulin in Alzheimer's disease: Food for thought

Chapman CD, Schiöth HB, Grillo CA, Benedict C.

Neuropharmacology. 2018 Jul 1;136(Pt B):196-201. doi: 10.1016/j.neuropharm.2017.11.037. Epub 2017 Nov 24.

Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease

Alam J, Blackburn K, Patrick D.

J Prev Alzheimers Dis. 2017;4(4):273-278. doi: 10.14283/jpad.2017.41.

Multimedia Aided Consent for Alzheimer's Disease Research

Palmer BW, Harmell AL, Dunn LB, Kim SY, Pinto LL, Golshan S, Jeste DV.

Clin Gerontol. 2018 Jan-Feb;41(1):20-32. doi: 10.1080/07317115.2017.1373177. Epub 2017 Nov 28.

Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease: Alzheimer's disease / Analisi qualitativa sulla capacità a prestare consenso al trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche: Demenza di Alzheimer

Carabellese F, Felthous AR, La Tegola D, Piazzolla G, Distaso S, Logroscino G, Leo A, Ventriglio A, Catanesi R.

Int J Soc Psychiatry. 2018 Feb;64(1):26-36. doi: 10.1177/0020764017739642. Epub 2017 Nov 28.

Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease

Sadhukhan P, Saha S, Dutta S, Mahalanobish S, Sil PC.

Pharmacol Res. 2018 Mar;129:100-114. doi: 10.1016/j.phrs.2017.11.028. Epub 2017 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias